Chronic rhinitis
Conditions
Interventions
All the 40 individuals included in the study will be submitted to skin prick allergy test, spirometry and blood tests. Furthermore, in these will be measured the peak flow nasal inspiratory before and
Drug
Sponsors
Programa de Pós Graduação em Ciências Médicas da Universidade Federal Fluminense
Hospital Universitário Antônio Pedro
Eligibility
Age
60 Years to 120 Years
Inclusion criteria
Inclusion criteria: Adults with symptoms of chronic rhinitis, two or more symptoms of nasal blockage, rhinorrhea, sneeze or nasal itching for 1 hour or more and for two weeks or more; age equal or above 60 years old; monitored clinically in the departament of allergy and immunology of Hospital Universitário Antônio Pedro.
Exclusion criteria
Exclusion criteria: Primary or secondary immunodeficiency; mechanical obstruction of upper airways; respiratory infection in the last two weeks; impossible to perform spirometry before and after bronchodilator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in nasal patency of the elderly with rhinitis after two weeks of treatment assessed by the peak nasal inspiratory flow (PNIF). That is, increase of at least 30 L/min in the PNIF after two weeks of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of at least 15 points in the sinonasal outcome test (SNOT-22) of the elderly with rhinitis after two weeks of treatment;Reduction of at least 2 points in the severity of symptoms assessed by a 10-point visual analogic scale (VAS) of the elderly with rhinitis after two weeks of treatment | — |
Countries
Brazil
Contacts
Public ContactJosé Laerte;Victor Morandi;de Carvalho
Hospital Universitário Antônio Pedro;Hospital Universitário Antônio Pedro
Outcome results
None listed